BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34638216)

  • 1. [Role of CXCL12-CXCR4/CXCR7 signal axis in liver regeneration and liver fibrosis].
    Cui LN; Zheng XH; Yu JH; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):900-903. PubMed ID: 34638216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis.
    Ding BS; Cao Z; Lis R; Nolan DJ; Guo P; Simons M; Penfold ME; Shido K; Rabbany SY; Rafii S
    Nature; 2014 Jan; 505(7481):97-102. PubMed ID: 24256728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
    Liepelt A; Tacke F
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G203-9. PubMed ID: 27313175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
    Gonçalves TL; de Araújo LP; Pereira Ferrer V
    Cytokine; 2023 Oct; 170():156344. PubMed ID: 37639844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
    Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
    Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies.
    Daniel SK; Seo YD; Pillarisetty VG
    Semin Cancer Biol; 2020 Oct; 65():176-188. PubMed ID: 31874281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.
    Mühlethaler-Mottet A; Liberman J; Ascenção K; Flahaut M; Balmas Bourloud K; Yan P; Jauquier N; Gross N; Joseph JM
    PLoS One; 2015; 10(5):e0125616. PubMed ID: 25955316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin protects against hepatic stellate cells activation and migration by inhibiting the CXCL12/CXCR4 biological axis in liver fibrosis:A study in vitro and in vivo.
    Qin L; Qin J; Zhen X; Yang Q; Huang L
    Biomed Pharmacother; 2018 May; 101():599-607. PubMed ID: 29518606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL12/CXCR4/CXCR7 Chemokine Axis in the Central Nervous System: Therapeutic Targets for Remyelination in Demyelinating Diseases.
    Chu T; Shields LBE; Zhang YP; Feng SQ; Shields CB; Cai J
    Neuroscientist; 2017 Dec; 23(6):627-648. PubMed ID: 29283028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies.
    Mehrpouri M
    Eur J Pharmacol; 2022 Apr; 920():174831. PubMed ID: 35183534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions.
    Huynh C; Dingemanse J; Meyer Zu Schwabedissen HE; Sidharta PN
    Pharmacol Res; 2020 Nov; 161():105092. PubMed ID: 32758634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the SDF-1 chemokine receptors CXCR4 and CXCR7 during mouse limb muscle development and regeneration.
    Hunger C; Ödemis V; Engele J
    Exp Cell Res; 2012 Oct; 318(17):2178-90. PubMed ID: 22766125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice.
    Wilson GC; Freeman CM; Kuethe JW; Quillin RC; Nojima H; Schuster R; Blanchard J; Edwards MJ; Caldwell CC; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(8):G702-9. PubMed ID: 25721302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.